Safety and Immunogenicity Among Healthy Children Receiving Fluzone Quadrivalent Influenza Virus Vaccine (2013-2014 Formulation)
Phase of Trial: Phase IV
Latest Information Update: 07 Oct 2014
Price : $35 *
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Sanofi
- 17 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 09 Jan 2014 Planned End Date changed from 1 Mar 2014 to 1 Jul 2014, according to ClinicalTrials.gov record.
- 09 Jan 2014 Status changed from recruiting to active, no longer recruiting; according to ClinicalTrials.gov record.